Joseph M Lynch, MD | |
420 Delaware Dr, Fort Washington, PA 19034-2711 | |
(215) 273-7717 | |
(215) 273-4265 |
Full Name | Joseph M Lynch |
---|---|
Gender | Male |
Speciality | Internal Medicine - Infectious Disease |
Location | 420 Delaware Dr, Fort Washington, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275692170 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | MD036584E (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Joseph M Lynch, MD Po Box 265, Fort Washington, PA 19034-0265 Ph: (215) 273-7717 | Joseph M Lynch, MD 420 Delaware Dr, Fort Washington, PA 19034-2711 Ph: (215) 273-7717 |
News Archive
House Republican lawmakers are questioning hiring practices at the Department of Health and Human Services as well as how the Internal Revenue Service will enforce provisions of the health law.
GE Healthcare Medical Diagnostics today announced the market reintroduction of Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in select echocardiograms. Optison is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borders. The safety and efficacy of Optison with exercise stress or pharmacologic stress testing have not been established.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for cardiovascular diseases, today announced that the U.S. Patent and Trademark Office has issued a patent on methods for treating patients with bucindolol based on genetic targeting and focused on a specific genotype - homozygous wildtype for Deletion 322-325 in the alpha-2C adrenergic receptor.
The Vermont Legislature has passed legislation (S 48) that bans nearly all gifts from pharmaceutical and medical device companies to health care providers, administrators and facilities in the state, the New York Times reports.
Scientists looking for new ways to fight tuberculosis have their sights set on a structure essential to the bacterium's survival. Disabling this structure could kill the microbes in the infected host and thwart TB infections. In a study appearing online May 11, 2010, in EMBO J, the journal of the European Molecular Biology Organization, scientists from the U.S. Department of Energy's Brookhaven National Laboratory, Stony Brook University, and Weill Cornell Medical College describe new features of how this structure, known as a proteasome, is put together and how it works.
› Verified 7 days ago
Dr. David E Lipkin, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 9 Pinetree Pl, Fort Washington, PA 19034 Phone: 215-605-8816 Fax: 888-718-1827 | |
Dr. Joel Chinitz, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 265 Wenner Way, Fort Washington, PA 19034 Phone: 215-646-1381 | |
Trudy Samuels, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 5 Camp Hill Rd, Fort Washington, PA 19034 Phone: 215-421-2227 |